Nano Discovery Inc.
Nano Discovery is dedicated to the development and commercialization of novel and proprietary high value molecular diagnostics for cancer.
Current prostate cancer diagnostic testing fails to clearly and accurately classify one third of tumors as indolent or aggressive, resulting in a significant number of over-treatment. Nano Discovery, Inc. is developing a novel, proprietary diagnostic test with the potential to identify aggressive prostate cancer from indolent tumor. Nano Discovery’s new test will improve patient outcomes and reduce costs to the healthcare system.